Abstract:Porcine beta-defensin 2 (PBD-2) which is a member of the family of antimicrobial peptides, is widely expressed in pig organs with a broad spectrum of bactericidal activities confirmed in vitro. We previously demonstrated that transgenic (TG) pigs overexpressing PBD-2 could resist the infection by the porcine pathogen Actinobacillus pleuropneumoniae. In this study, the roles of PBD-2 in protecting against bacterial infection were further investigated. The biochemical indexes of the blood sample, body weights, histological morphologies, and weights of the organs of TG mice expressing PBD-2 were measured. Results confirmed that these mice showed normal physiological features. An assay of Salmonella Typhimurium infection was conducted on wild-type (WT) and TG mice. The TG mice possessed higher survival rate, less body weight loss, and pathological changes and smaller recovery rates of bacteria after infection with S. Typhimurium. The in vitro synthetic PBD-2 and the serum and tissue homogenates from the TG mice displayed a direct bactericidal activity. Moreover, PBD-2 could inhibit the release of the proinflammatory cytokines, including IL-6, TNF-α, IL-1β, and IL-12, in the TG mice infected with S. Typhimurium or treated with lipopolysaccharide (LPS). The WT mice treated with PBD-2 and S. Typhimurium or LPS showed reduced levels of proinflammatory cytokines. The mouse macrophage cell line RAW 264.7 which expressed PBD-2 was constructed to detect the signal pathways affected by PBD-2. The suppressing effect of PBD-2 on the release of the proinflammatory cytokines was confirmed using RAW 264.7 either expressing PBD-2 or supplemented with PBD-2. The promoter activity and mRNA level of NF-κB were detected, and PBD-2 was shown to significantly inhibit the activation of the NF-κB pathway induced by LPS. The direct interaction of PBD-2 with TLR4 was revealed by isothermal titration calorimetry and far-Western blot in vitro and the coimmunoprecipitation of PBD-2 with TLR4 on RAW 264.7 cells. This interaction indicates one reason for the interference of NF-κB activation. Overall, this study showed that PBD-2 protected against bacterial infection through a direct bactericidal activity and alleviated inflammation by interfering with the TLR4/NF-κB pathway.

The chromosomal protein HMGN2 mediates lipopolysaccharide-induced expression of β-defensins in A549 cells

Transcriptional regulation of beta-defensin-2 by lipopolysaccharide in cultured human cervical carcinoma (HeLa) cells

MEF up-regulates human beta-defensin 2 expression in epithelial cells

Preferential codons enhancing the expression level of human beta-defensin-2 in recombinant Escherichia coli.

TLR2/4-mediated NF-κB Pathway Combined with the Histone Modification Regulates Β-Defensins and Interleukins Expression by Sodium Phenyl Butyrate in Porcine Intestinal Epithelial Cells

Cloning and Expression of Human Beta-Defensin-2 Gene in Escherichia Coli

Regulation of Β-Defensin-2 Gene Expression by Lentinan in Human Pulmonary Epithelial Cells

Expression of human β-defensin-2 with multiple joined genes in Escherichia coli

Expression of human beta-defensin-2 with multiple joined genes in Escherichia coli.

Bacillus subtilis Induces Human Beta Defensin-2 Through its Lipoproteins in Human Intestinal Epithelial Cells

NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2

TLR2/EGFR Are Two Sensors for Pbd3 and Pep2c Induction by Sodium Butyrate Independent of HDAC Inhibition

Fusion expression of human beta-defensin-2 from multiple joined genes in Escherichia coli.

The Intracellular Interaction of Porcine β-Defensin 2 with VASH1 Alleviates Inflammation via Akt Signaling Pathway

β-Defensin 2 and 3 promote the uptake of self or CpG DNA, enhance IFN-α production by human plasmacytoid dendritic cells, and promote inflammation

High-level Expression of Soluble Human Β-Defensin-2 in Escherichia Coli

Porcine Beta-Defensin 2 Provides Protection Against Bacterial Infection by a Direct Bactericidal Activity and Alleviates Inflammation Via Interference with the TLR4/NF-κB Pathway.

Advancement of Human Βdefensin-2 and Its Role in Pulmonary Diseases

Human β-Defensin 2 Mediated Immune Modulation as Treatment for Experimental Colitis

Enhanced Expression of Human Β-Defensin 2 in Peripheral Lungs of Patients with Chronic Obstructive Pulmonary Disease

The truncated human beta-defensin 118 can modulate lipopolysaccharide mediated inflammatory response in RAW264.7 macrophages